NCT04778228

Brief Summary

The aim of this study is to make analysis of potentially modifiable factors contributing to outcome of mechanically ventilated ARDS adult patient receiving lung protective strategy. Primary Objective: is to evaluate whether DP was superior to the variables that define it in predicting hospital outcome including mortality. Secondary Objective: is to identify manageable factors associated with outcome such as ventilator-related parameters and to investigate the role of non-modifiable factors such as demographic characteristics, severity of illness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2021

Completed
16 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

March 3, 2021

Status Verified

February 1, 2021

Enrollment Period

1.5 years

First QC Date

February 13, 2021

Last Update Submit

February 26, 2021

Conditions

Keywords

Driving pressure

Outcome Measures

Primary Outcomes (1)

  • driving pressure

    more than or less than 14 cmH2O

    during intubation UP TO 28 days

Secondary Outcomes (1)

  • ventilator free days and hospital stay.

    28 days

Interventions

critically ill patients requiring mechanical ventilation (MV) were ventilated using high tidal volumes (Vt) and high airway pressures, until the pivotal ARDS net randomized controlled trial (RCT) demonstrated that a "lung-protective" MV strategy using a Vt of 4-8 mL/kg predicted body weight (PBW) and moderate levels of positive end-expiratory pressure (PEEP) improved survival (2). Since then, limitation of Vt to 4-8 mL/kg PBW, plateau pressures (Pplat) to a maximum of 30 cm H2O, and application of PEEP 10 -16 cm H2O represent the standard for MV in ARDS patients.

Also known as: protective lung strategy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inclusion criteria: ARDS Patients: who are treated with lung-protective MV and assessed on standardized ventilatory settings(4) at 24 hours after ARDS onset . All patients will meet the American-European Consensus Conference criteria for ARDS (5) on PEEP greater than or equal to 5 cm H2O and Berlin criteria for moderate or severe ARDS (6). Exclusion criteria: * Patients with left atrial hypertension, as diagnosed by the attending physician, as the primary cause of respiratory failure. * Anticipated duration of mechanical ventilation of less than 48 hours. * Severe chronic respiratory disease; neuromuscular disease that would prolong mechanical ventilation. * Intracranial hypertension; morbid obesity; pregnancy.

You may qualify if:

  • ARDS Patients: who are treated with lung-protective MV and assessed on standardized ventilatory settings(4) at 24 hours after ARDS onset . All patients will meet the American-European Consensus Conference criteria for ARDS (5) on PEEP greater than or equal to 5 cm H2O and Berlin criteria for moderate or severe ARDS (6).

You may not qualify if:

  • Patients with left atrial hypertension, as diagnosed by the attending physician, as the primary cause of respiratory failure.
  • Anticipated duration of mechanical ventilation of less than 48 hours.
  • Severe chronic respiratory disease; neuromuscular disease that would prolong mechanical ventilation.
  • Intracranial hypertension; morbid obesity; pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut university hospital

Asyut, Egypt

Location

MeSH Terms

Interventions

Respiration, Artificial

Intervention Hierarchy (Ancestors)

Airway ManagementTherapeuticsResuscitationEmergency TreatmentRespiratory Therapy

Central Study Contacts

shahenda mohamed gamal

CONTACT

maha kamel ghanem

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator (assistant lecturer at Assiut university)

Study Record Dates

First Submitted

February 13, 2021

First Posted

March 3, 2021

Study Start

March 1, 2021

Primary Completion

September 1, 2022

Study Completion

January 1, 2023

Last Updated

March 3, 2021

Record last verified: 2021-02

Locations